Novel dual-targeted protein specifically binding to DLL4 AND VEGf, and use thereof
A dual-targeting, specific technology, applied in the direction of hybrid immunoglobulin, anti-animal/human immunoglobulin, immunoglobulin, etc., to achieve excellent binding affinity and excellent anti-cancer effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0127] Example 1: Preparation of anti-DLL4 / VEGF dual targeting protein
Embodiment 1-1
[0128] Example 1-1: Preparation of DLL4 antigen
[0129] As the extracellular domain antigen of human DLL4, human DLL4 protein (catalog number: 1506-D4 / CF) purchased from R&D System was used. The DLL4 antigen includes amino acid residues 27-524 of the DLL4 amino acid sequence (accession number Q9NR61). The C-terminus of the protein has a 10-His tag.
[0130] Prepare antigens corresponding to specific regions of DLL4 extracellular domain. This specific region contains amino acid residues 27-251. This region contains a motif called "DSL(δ / Serrate) / lag-2)" domain known to bind to Noth1 receptor. A mammalian expression vector plasmid containing the CMV promoter upstream of the polynucleotide encoding the DLL4 extracellular domain deleted fragment (amino acid residues 27-251) fused to the Fc protein was prepared using standard recombinant DNA technology. Other constructs encoding DLL4 deletion fragments of human DLL4 chimera fused with Fc protein were prepared using general recombi...
Embodiment 1-2
[0131] Example 1-2: Preparation of phage library
[0132] 2.7x10 with diversity 10 Human scFv (single-chain variable fragment) library cells contain 17g2XYTCM (tryptone (CONDA, 1612.00), 10g yeast extract (CONDA, 1702.00), 5gNaCl (Sigma, S7653-5kg), 34μg / ml chloramphenicol (Sigma ,C0857)], 2% glucose (Sigma, G5400) and 5mMMgCl 2 (Sigma, M2393) culture medium (3L) at 37℃ for 2-3 hours (OD 600 =0.5-0.7), the cells were then infected with helper phage and cultured in 2XYTCMK medium (2XYTCM, 70μg / ml kanamycin (Sigma, K1876), 1mMIPTG (ELPISBIO, IPTG025)) at 30°C for 16 hours. The cultured cells were centrifuged (4500 rpm, 15 minutes, 4°C), and the supernatant was added and dissolved in 4% PEG (Fluka, 81253) 6000 and 3% NaCl (Sigma, S7653), and then incubated on ice 1 hour. Subsequently, the solution was centrifuged (8000 rpm, 20 minutes, 4°C), and the precipitate was added and dissolved in PBS and then centrifuged (12000 rpm, 10 minutes, 4°C). The supernatant containing the phage l...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com